Drug class review on targeted immune modulators final report

Targeted immune modulators are used in the treatment of certain types of immunologic and inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. These drugs work...

Full description

Bibliographic Details
Main Author: Gartlehner, Gerald
Corporate Authors: Cecil G. Sheps Center for Health Services Research, RTI International-University of North Carolina Evidence-based Practice Center, Oregon Health & Science University Evidence-based Practice Center, Oregon Health & Science University, Drug Effectiveness Review Project
Format: eBook
Language:English
Published: Portland, Oregon Oregon Health & Science University [2006], 2006
Series:Drug class reviews
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02694nam a2200421 u 4500
001 EB002001401
003 EBX01000000000000001164302
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Gartlehner, Gerald 
245 0 0 |a Drug class review on targeted immune modulators  |h Elektronische Ressource  |b final report  |c Gerald Gartlehner [and 5 others] ; produced by RTI-UNC Evidence-based Practice Center, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill [and] Oregon Evidence-based Practice Center 
246 3 1 |a Targeted immune modulators 
260 |a Portland, Oregon  |b Oregon Health & Science University  |c [2006], 2006 
300 |a 1 PDF file (148 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Antirheumatic Agents / therapeutic use 
653 |a Drug Evaluation 
653 |a Antibodies, Monoclonal / therapeutic use 
653 |a Immunologic Factors / therapeutic use 
653 |a Immunoglobulin G / therapeutic use 
653 |a Recombinant Fusion Proteins / therapeutic use 
653 |a Immunoconjugates / therapeutic use 
653 |a Interleukin 1 Receptor Antagonist Protein / therapeutic use 
653 |a Treatment Outcome 
710 2 |a Cecil G. Sheps Center for Health Services Research 
710 2 |a RTI International-University of North Carolina Evidence-based Practice Center 
710 2 |a Oregon Health & Science University  |b Evidence-based Practice Center 
710 2 |a Oregon Health & Science University 
710 2 |a Drug Effectiveness Review Project 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Drug class reviews 
500 |a Title from PDF title page. - "January 2007." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK10567  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
856 4 0 |u http://www.donau-uni.ac.at/imperia/md/content/department/evidenzbasierte_medizin/abstracts_publikationen_gerald/drug_class_review_on_targeted_immune_modulators.pdf  |3 Volltext  |n Free Electronic Resource  |3 Volltext 
082 0 |a 610 
520 |a Targeted immune modulators are used in the treatment of certain types of immunologic and inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by selectively blocking mechanisms involved in the inflammatory and immune response. The purpose of this review is to help policy makers and clinicians make informed choices about the use of targeted immune modulators